The National Birth Defects Prevention Study of Infants has announced that it has made public statistics raising concerns about links between two serious forms of birth defects that the group says may be caused by Prozac and other types of SSRI anti-depressants.
The study found that women who use Prozac or the other drugs during their pregnancies are at a higher risk of giving birth to infants suffering from omphalocele, an abdominal wall defect, and craniosynostosis, a defect that can cause abnormally shaped heads.
These findings increase the number of possible birth defects that consumer advocates and medical researchers have cited that Prozac and other SSRIs can cause in infants born to women who used the drugs while pregnant. One of the most commonly other defect cited is a condition called PPHN, or persistent pulmonary hypertension of the newborn, in which an abnormal flow of blood through the child’s heart and lungs can cause death. Many times parents are seeking information on Prozac birth defects lawsuits.
The Food and Drug Administration has issued a warning based on these concerns and informed the public and health care professionals about these dangerous side effects and directed the drug manufacturers to outline those issues on their labeling.
Prozac and other SSRIs also have been defending themselves against an increasing number of lawsuits that have been filed on behalf of victims of these side effects. This litigation is being handled by experienced drug-defect lawyers who have a history of winning millions of dollars in out-of-court settlements and jury verdicts against large pharmaceutical firms. According to court records they are offering free legal consultations to Prozac victims.